Ergoloid Mesylates

Ergoloid Mesylates is used in the treatment of Alzheimer's disease, stroke, dementia in Parkinson's disease, age related memory loss and head injury.

Ergoloid Mesylates is a fungal derivative. It has a dual mechanism of action of partial agonism/antagonism on adrenergic, dopaminergic and serotonergic receptors. It acts centrally, decreasing vascular tone and slowing the heart rate, and acts peripherally to block alpha-receptors. One other possible mechanism is the effect of Ergoloid Mesylates on neuronal cell metabolism, resulting in improved oxygen uptake and cerebral metabolism, thereby normalizing depressed neurotransmitter levels.

Vomiting, Lightheadedness, Loss of appetite, Runny nose, Upset stomach, Tongue irritation, Flushing (sense of warmth in the face, ears, neck and trunk)